Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$180,000.00
Agreement Date:
Jul 1, 2013 - Jun 30, 2016
Description:
BRUISE CONTROL-2: A randomized controlled trial to investigate whether a strategy of Continued versus Interrupted Dabigatran at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events, leads to a reduction in the incidence of clinically significant hematoma
Organization:
Canadian Institutes of Health Research
Location:
Montreal, Quebec, CA H3A 2T5
Reference Number:
236-2013-2014-Q1-00052
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2013-14 to 2016-17)

Recipient's Legal Name:
ESSEBAG, Vidal
Research Organization:
McGill University|Université McGill